Dr. Gabriel Pardo
Claim this profileOklahoma Medical Research Foundation
Affiliated Hospitals
Oklahoma Medical Research Foundation
Multiple Sclerosis Center Of Excellence Of OMRF
Clinical Trials Gabriel Pardo is currently running
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.
Recruiting
2 awards
Phase 3
Ocrelizumab
for Multiple Sclerosis
This trial is testing if patients with early relapsing multiple sclerosis can stop taking Ocrelizumab after initial treatment without their disease getting worse. Ocrelizumab is a medication given through an IV that helps manage multiple sclerosis by reducing harmful immune cells. The study will monitor patients for new disease activity over several years.
Recruiting
2 awards
Phase 4
More about Gabriel Pardo
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Gabriel Pardo has experience with
- Ocrelizumab
- Early Aggressive Therapy
- Traditional Therapy
- Placebo
- RPC-1063
- MSCopilot® Mobile Application
Breakdown of trials Gabriel Pardo has run
Multiple Sclerosis
Radiologically Isolated Syndrome
Motor and sensory neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gabriel Pardo specialize in?
Gabriel Pardo focuses on Multiple Sclerosis and Relapse. In particular, much of their work with Multiple Sclerosis has involved unknown patients, or patients who are undergoing treatment.
Is Gabriel Pardo currently recruiting for clinical trials?
Yes, Gabriel Pardo is currently recruiting for 3 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Gabriel Pardo has studied deeply?
Yes, Gabriel Pardo has studied treatments such as Ocrelizumab, Early Aggressive Therapy, Traditional Therapy.
What is the best way to schedule an appointment with Gabriel Pardo?
Apply for one of the trials that Gabriel Pardo is conducting.
What is the office address of Gabriel Pardo?
The office of Gabriel Pardo is located at: Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the Oklahoma Medical Research Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.